APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enfuvirtide for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enfuvirtide for Injection Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchEnfuvirtide for Injection Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Enfuvirtide for Injection Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Enfuvirtide for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enfuvirtide for Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Enfuvirtide for Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Enfuvirtide for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enfuvirtide for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enfuvirtide for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enfuvirtide for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enfuvirtide for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Enfuvirtide for Injection include Roche and Chengdu Shengnuo Biotechnology etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enfuvirtide for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enfuvirtide for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Enfuvirtide for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enfuvirtide for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enfuvirtide for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enfuvirtide for Injection sales, projected growth trends, production technology, application and end-user industry.

Enfuvirtide for Injection Segment by Company

Roche

Chengdu Shengnuo Biotechnology

Enfuvirtide for Injection Segment by Type

90mg per Vial

108mg per Vial

Enfuvirtide for Injection Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enfuvirtide for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enfuvirtide for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enfuvirtide for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enfuvirtide for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enfuvirtide for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enfuvirtide for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enfuvirtide for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enfuvirtide for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 90mg per Vial Major Manufacturers Table 3. 108mg per Vial Major Manufacturers Table 4. Global Enfuvirtide for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Other Major Manufacturers Table 8. Enfuvirtide for Injection Industry Trends Table 9. Enfuvirtide for Injection Industry Drivers Table 10. Enfuvirtide for Injection Industry Opportunities and Challenges Table 11. Enfuvirtide for Injection Industry Restraints Table 12. Global Enfuvirtide for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Enfuvirtide for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Enfuvirtide for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Enfuvirtide for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Enfuvirtide for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Enfuvirtide for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Enfuvirtide for Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Enfuvirtide for Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Enfuvirtide for Injection Sales Market Share by Region (2021-2026) Table 21. Global Enfuvirtide for Injection Sales Market Share by Region (2027-2032) Table 22. Global Enfuvirtide for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Enfuvirtide for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Enfuvirtide for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Enfuvirtide for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Enfuvirtide for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Enfuvirtide for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Enfuvirtide for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Enfuvirtide for Injection Manufacturers, Product Type & Application Table 30. Global Enfuvirtide for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Enfuvirtide for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Enfuvirtide for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Enfuvirtide for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Enfuvirtide for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Enfuvirtide for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Enfuvirtide for Injection Sales Market Share by Type (2021-2026) Table 42. Global Enfuvirtide for Injection Sales Market Share by Type (2027-2032) Table 43. Global Enfuvirtide for Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Enfuvirtide for Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Enfuvirtide for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Enfuvirtide for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Enfuvirtide for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Enfuvirtide for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Enfuvirtide for Injection Sales Market Share by Application (2021-2026) Table 54. Global Enfuvirtide for Injection Sales Market Share by Application (2027-2032) Table 55. Global Enfuvirtide for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enfuvirtide for Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Roche Company Information Table 58. Roche Business Overview Table 59. Roche Enfuvirtide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Roche Enfuvirtide for Injection Product Portfolio Table 61. Roche Recent Development Table 62. Chengdu Shengnuo Biotechnology Company Information Table 63. Chengdu Shengnuo Biotechnology Business Overview Table 64. Chengdu Shengnuo Biotechnology Enfuvirtide for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Chengdu Shengnuo Biotechnology Enfuvirtide for Injection Product Portfolio Table 66. Chengdu Shengnuo Biotechnology Recent Development Table 67. North America Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 70. North America Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 71. North America Enfuvirtide for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Enfuvirtide for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 76. North America Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 77. North America Enfuvirtide for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Enfuvirtide for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Enfuvirtide for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Enfuvirtide for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Enfuvirtide for Injection Sales by Country (2021-2026) & (K Units) Table 84. North America Enfuvirtide for Injection Sales by Country (2027-2032) & (K Units) Table 85. North America Enfuvirtide for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Enfuvirtide for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 88. Canada Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 89. Mexico Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 90. Europe Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 93. Europe Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 94. Europe Enfuvirtide for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Enfuvirtide for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 99. Europe Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 100. Europe Enfuvirtide for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Enfuvirtide for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Enfuvirtide for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Enfuvirtide for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Enfuvirtide for Injection Sales by Country (2021-2026) & (K Units) Table 107. Europe Enfuvirtide for Injection Sales by Country (2027-2032) & (K Units) Table 108. Europe Enfuvirtide for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Enfuvirtide for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 111. France Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 112. U.K. Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 113. Italy Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 114. Russia Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 115. Spain Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 118. Sweden Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 119. Poland Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 120. China Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 121. China Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 122. China Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 123. China Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 124. China Enfuvirtide for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Enfuvirtide for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 127. China Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 128. China Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 129. China Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 130. China Enfuvirtide for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Enfuvirtide for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 135. Asia Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 136. Asia Enfuvirtide for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Enfuvirtide for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 141. Asia Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 142. Asia Enfuvirtide for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Enfuvirtide for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Enfuvirtide for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Enfuvirtide for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Enfuvirtide for Injection Sales by Country (2021-2026) & (K Units) Table 149. Asia Enfuvirtide for Injection Sales by Country (2027-2032) & (K Units) Table 150. Asia Enfuvirtide for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Enfuvirtide for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 153. South Korea Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 154. India Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 155. Australia Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Enfuvirtide for Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Enfuvirtide for Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Enfuvirtide for Injection Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Enfuvirtide for Injection Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Enfuvirtide for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Enfuvirtide for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Enfuvirtide for Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Enfuvirtide for Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Enfuvirtide for Injection Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Enfuvirtide for Injection Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Enfuvirtide for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Enfuvirtide for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Enfuvirtide for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Enfuvirtide for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Enfuvirtide for Injection Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Enfuvirtide for Injection Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Enfuvirtide for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Enfuvirtide for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 179. Argentina Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 180. Chile Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 181. Colombia Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 182. Peru Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 184. Israel Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 185. UAE Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 186. Turkey Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 187. Iran Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 188. Egypt Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Enfuvirtide for Injection Distributors List Table 192. Enfuvirtide for Injection Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Enfuvirtide for Injection Image Figure 2. Global Enfuvirtide for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enfuvirtide for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 90mg per Vial Image Figure 5. 108mg per Vial Image Figure 6. Global Enfuvirtide for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Enfuvirtide for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Retail Pharmacies Image Figure 10. Other Image Figure 11. Global Enfuvirtide for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Enfuvirtide for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Enfuvirtide for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Enfuvirtide for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Enfuvirtide for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Enfuvirtide for Injection Sales (2021-2032) & (K Units) Figure 17. Global Enfuvirtide for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Enfuvirtide for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Enfuvirtide for Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Enfuvirtide for Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Enfuvirtide for Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Enfuvirtide for Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Enfuvirtide for Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Enfuvirtide for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Enfuvirtide for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Enfuvirtide for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Enfuvirtide for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Enfuvirtide for Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Enfuvirtide for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Enfuvirtide for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Enfuvirtide for Injection Sales Market Share by Type (2021-2032) Figure 33. Global Enfuvirtide for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Enfuvirtide for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Enfuvirtide for Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Enfuvirtide for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Enfuvirtide for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Enfuvirtide for Injection Sales Market Share by Application (2021-2032) Figure 39. North America Enfuvirtide for Injection Revenue Share by Type (2021-2032) Figure 40. North America Enfuvirtide for Injection Sales Share by Type (2021-2032) Figure 41. North America Enfuvirtide for Injection Revenue Share by Application (2021-2032) Figure 42. North America Enfuvirtide for Injection Sales Share by Application (2021-2032) Figure 43. North America Enfuvirtide for Injection Revenue Share by Country (2021-2032) Figure 44. North America Enfuvirtide for Injection Sales Share by Country (2021-2032) Figure 45. Europe Enfuvirtide for Injection Revenue Share by Type (2021-2032) Figure 46. Europe Enfuvirtide for Injection Sales Share by Type (2021-2032) Figure 47. Europe Enfuvirtide for Injection Revenue Share by Application (2021-2032) Figure 48. Europe Enfuvirtide for Injection Sales Share by Application (2021-2032) Figure 49. Europe Enfuvirtide for Injection Revenue Share by Country (2021-2032) Figure 50. Europe Enfuvirtide for Injection Sales Share by Country (2021-2032) Figure 51. China Enfuvirtide for Injection Revenue Share by Type (2021-2032) Figure 52. China Enfuvirtide for Injection Sales Share by Type (2021-2032) Figure 53. China Enfuvirtide for Injection Revenue Share by Application (2021-2032) Figure 54. China Enfuvirtide for Injection Sales Share by Application (2021-2032) Figure 55. Asia Enfuvirtide for Injection Revenue Share by Type (2021-2032) Figure 56. Asia Enfuvirtide for Injection Sales Share by Type (2021-2032) Figure 57. Asia Enfuvirtide for Injection Revenue Share by Application (2021-2032) Figure 58. Asia Enfuvirtide for Injection Sales Share by Application (2021-2032) Figure 59. Asia Enfuvirtide for Injection Revenue Share by Country (2021-2032) Figure 60. Asia Enfuvirtide for Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Enfuvirtide for Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Enfuvirtide for Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Enfuvirtide for Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Enfuvirtide for Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Enfuvirtide for Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Enfuvirtide for Injection Sales Share by Country (2021-2032) Figure 67. Enfuvirtide for Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Enfuvirtide for Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 90mg per Vial
  • 108mg per Vial
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Roche
  • Chengdu Shengnuo Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enfuvirtide for Injection Market by Type
  3. 1.2.1 Global Enfuvirtide for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 90mg per Vial
  5. 1.2.3 108mg per Vial
  6. 1.3 Enfuvirtide for Injection Market by Application
  7. 1.3.1 Global Enfuvirtide for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Enfuvirtide for Injection Market Dynamics
  1. 2.1 Enfuvirtide for Injection Industry Trends
  2. 2.2 Enfuvirtide for Injection Industry Drivers
  3. 2.3 Enfuvirtide for Injection Industry Opportunities and Challenges
  4. 2.4 Enfuvirtide for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enfuvirtide for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enfuvirtide for Injection Revenue by Region
  3. 3.2.1 Global Enfuvirtide for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enfuvirtide for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Enfuvirtide for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Enfuvirtide for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enfuvirtide for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enfuvirtide for Injection Sales by Region
  9. 3.4.1 Global Enfuvirtide for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enfuvirtide for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Enfuvirtide for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Enfuvirtide for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enfuvirtide for Injection Revenue by Manufacturers
  2. 4.1.1 Global Enfuvirtide for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enfuvirtide for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enfuvirtide for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enfuvirtide for Injection Sales by Manufacturers
  6. 4.2.1 Global Enfuvirtide for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enfuvirtide for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enfuvirtide for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enfuvirtide for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enfuvirtide for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enfuvirtide for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enfuvirtide for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Enfuvirtide for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enfuvirtide for Injection Market CR5 and HHI
  16. 4.8.2 2025 Enfuvirtide for Injection Tier 1, Tier 2, and Tier 3
5 Enfuvirtide for Injection Market by Type
  1. 5.1 Global Enfuvirtide for Injection Revenue by Type
  2. 5.1.1 Global Enfuvirtide for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enfuvirtide for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enfuvirtide for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enfuvirtide for Injection Sales by Type
  6. 5.2.1 Global Enfuvirtide for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enfuvirtide for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Enfuvirtide for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enfuvirtide for Injection Price by Type
6 Enfuvirtide for Injection Market by Application
  1. 6.1 Global Enfuvirtide for Injection Revenue by Application
  2. 6.1.1 Global Enfuvirtide for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enfuvirtide for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enfuvirtide for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enfuvirtide for Injection Sales by Application
  6. 6.2.1 Global Enfuvirtide for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enfuvirtide for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Enfuvirtide for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enfuvirtide for Injection Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Enfuvirtide for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Enfuvirtide for Injection Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Chengdu Shengnuo Biotechnology
  8. 7.2.1 Chengdu Shengnuo Biotechnology Company Information
  9. 7.2.2 Chengdu Shengnuo Biotechnology Business Overview
  10. 7.2.3 Chengdu Shengnuo Biotechnology Enfuvirtide for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chengdu Shengnuo Biotechnology Enfuvirtide for Injection Product Portfolio
  12. 7.2.5 Chengdu Shengnuo Biotechnology Recent Developments
8 North America
  1. 8.1 North America Enfuvirtide for Injection Market Size by Type
  2. 8.1.1 North America Enfuvirtide for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Enfuvirtide for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Enfuvirtide for Injection Price by Type (2021-2032)
  5. 8.2 North America Enfuvirtide for Injection Market Size by Application
  6. 8.2.1 North America Enfuvirtide for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Enfuvirtide for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Enfuvirtide for Injection Price by Application (2021-2032)
  9. 8.3 North America Enfuvirtide for Injection Market Size by Country
  10. 8.3.1 North America Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enfuvirtide for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Enfuvirtide for Injection Market Size by Type
  2. 9.1.1 Europe Enfuvirtide for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enfuvirtide for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Enfuvirtide for Injection Price by Type (2021-2032)
  5. 9.2 Europe Enfuvirtide for Injection Market Size by Application
  6. 9.2.1 Europe Enfuvirtide for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enfuvirtide for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Enfuvirtide for Injection Price by Application (2021-2032)
  9. 9.3 Europe Enfuvirtide for Injection Market Size by Country
  10. 9.3.1 Europe Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enfuvirtide for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Enfuvirtide for Injection Market Size by Type
  2. 10.1.1 China Enfuvirtide for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Enfuvirtide for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Enfuvirtide for Injection Price by Type (2021-2032)
  5. 10.2 China Enfuvirtide for Injection Market Size by Application
  6. 10.2.1 China Enfuvirtide for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Enfuvirtide for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Enfuvirtide for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enfuvirtide for Injection Market Size by Type
  2. 11.1.1 Asia Enfuvirtide for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enfuvirtide for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Enfuvirtide for Injection Price by Type (2021-2032)
  5. 11.2 Asia Enfuvirtide for Injection Market Size by Application
  6. 11.2.1 Asia Enfuvirtide for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enfuvirtide for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Enfuvirtide for Injection Price by Application (2021-2032)
  9. 11.3 Asia Enfuvirtide for Injection Market Size by Country
  10. 11.3.1 Asia Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enfuvirtide for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enfuvirtide for Injection Market Size by Type
  2. 12.1.1 SAMEA Enfuvirtide for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enfuvirtide for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enfuvirtide for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Enfuvirtide for Injection Market Size by Application
  6. 12.2.1 SAMEA Enfuvirtide for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enfuvirtide for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enfuvirtide for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Enfuvirtide for Injection Market Size by Country
  10. 12.3.1 SAMEA Enfuvirtide for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enfuvirtide for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enfuvirtide for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enfuvirtide for Injection Value Chain Analysis
  2. 13.1.1 Enfuvirtide for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enfuvirtide for Injection Production Mode & Process
  6. 13.2 Enfuvirtide for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enfuvirtide for Injection Distributors
  9. 13.2.3 Enfuvirtide for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst